Abstract:Background Systemic sclerosis (SSc) is a chronic inflammatory disease with complex pathogenesis. The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg and Th17 cells as well as their associations with clinical characteristics of SSc are still unclear. Objectives The aim of the present study was to explore the relationship between absolute reduction of peripheral CD4 +regulatory T and Th17 cell subset and clinical characteristics in SSc patients. Methods The peripheral CD4 +T subsets from 54 patients with SSc and 30 healthy control subjects were analysed. The patients were divided into the untreated group (n=29) and treated group (n=25). The patients were also divided into group 1 (n=9) for the prominent pulmonary lesions, group 2 (n=5) for prominent esophageal involvement, group 3 (n=8) for both lung lesions and esophageal involvement, and group 4 (n=10) who had fingers swelling, sclerosis, ulceration prominent. Directly using the results from flow cytometry combined with internal standard beads, absolute number of peripheral Th17 and Treg cells from the subjects in each group were calculated. Results Although there were some changes among CD4 +T cell subsets in peripheral blood from these SSc patients, the major alteration was the reductions of Treg cell absolute number. Compared with the normal controls, the number of CD4+CD25+FOXP3+Treg cells were significantly decreased in untreated group (p=0.029) , in group 1 (p=0.014) and in group 2 (p=0.073) as compared with heathy controls. Interestingly, Tregs in group 2 were significantly lower than those in group 1 (p=0.006), in group 3(p=0.098) and in group 4(p=0.034). In addition, the number of Th17 cells were significantly higher in group 3 (p=0.003 and 4 (p Conclusions The absolute number of peripheral CD4 +CD25+FOXP3+Treg cells decreased in untreated patients, indicating that this reduction arising from the disease itself. Our findings suggest that the severity of clinical manifestations in patients with SSc is related to the absolute decrease of peripheral Treg cells. Although there was no statistically significant different, absolute number of the Treg cells trended to decrease in patients who had more severe clinical manifestations. With the involvement of vital organs, the absolute number of Treg cells decreased more significantly. Moreover, in patients with relatively mild clinical manifestations, the increase in the absolute number of Th17 cells is even more obvious, suggesting that Th17 also plays an important role in early and intermediate stages. Disclosure of Interest None declared

Expression and Significance of Intracellular IL-13 and IL-5 in Peripheral Blood CD4~+ and CD8~+ T Cells from Patients with Multiple Sclerosis

[Determination of Th1/Th2 Cytokines and Chemokines in Patients with Allergic Diseases and Its Significance].

Decreased Serum IL-22 Levels in Patients with Systemic Lupus Erythematosus

Increased Il-13 but Not Il-5 Production by Cd4-Positive T Cells and Cd8-Positive T Cells in Multiple Sclerosis During Relapse Phase

The Study on Secretion of Cytokine Interleukin-4, Interleukin-10 and Interferon-Γ in Peripheral Blood of Multiple Sclerosis Patients

A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis

Study on memory T cell subsets in peripheral blood of patients with multiple sclerosis

DIFFERENTIAL EXPRESSION OF PERIPHERAL CD4+T CELLS IN PATIENTS WITH SYSTEMIC SCLEROSIS AND MIXED CONNECTIVE TISSUE DISEASE

Study of the Expression of CD_4~+CD_(25)~+T Cell and Soluble Cytokines of Peripheral Blood in the Cases of Multiple Sclerosis

The detection and clinical significance of CD4~+CD25~+ regulatory T cell in peripheral blood of patients with multiple sclerosis and neuromyelitis optica

Serum Levels of Interleukin (IL)-18, IL-23 and IL-17 in Chinese Patients with Multiple Sclerosis

FRI0450 Associations of alterations of peripheral regulatory t and th17 absolute cell numbers with clinical features in patients with systemic sclerosis

Changes and clinical significance of peripheral CD28 － T‐cell subsets in patients with multiple sclerosis

IL-15 expression on B cells and myeloid cells is distinctly modulated by inflammatory factors in MS and healthy donors

Determination of Serum IL-2 and Auto-Antibody Against IL-2 in Patients with Multiple Sclerosis

Multiple Sclerosis is Associated with High Levels of Circulating Dendritic Cells Secreting Pro-Inflammatory Cytokines

Interleukin-2 Secreting Cells in Multiple Sclerosis and Controls

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis

The frequencies of peripheral blood CD5+CD19+ B cells, CD3−CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder

The Ratio of Circulating CD56dim NK Cells to Follicular T Helper Cells As a Promising Predictor for Disease Activity of Relapsing-Remitting Multiple Sclerosis

Expression and significance of interleukin-12 family cytokines in peripheral blood of patients with inflammatory bowel disease